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The use of genetic tools, imaging technologies and ex vivo culture systems has provided
signiﬁcant insights into the role of tissue inducer cells and associated signaling pathways
in the formation and function of lymphoid organs. Despite advances in experimental tech-
nologies, the molecular and cellular process orchestrating the formation of a complex
three-dimensional tissue is difﬁcult to dissect using current approaches.Therefore, a robust
set of simulation tools have been developed to model the processes involved in lymphoid
tissue development. Speciﬁcally, the role of different tissue inducer cell populations in the
dynamic formation of Peyer’s patches has been examined. Utilizing approaches from sys-
tems engineering, an unbiased model of lymphoid tissue inducer cell function has been
developed that permits the development of emerging behaviors that are statistically not
different from that observed in vivo. These results provide the conﬁdence to utilize statis-
tical methods to explore how the simulator predicts cellular behavior and outcomes under
different physiological conditions. Suchmethods, known as sensitivity analysis techniques,
can provide insight into when a component part of the system (such as a particular cell
type, adhesion molecule, or chemokine) begins to have an inﬂuence on observed behavior,
and quantiﬁes the effect a component part has on the end result: the formation of lymphoid
tissue.Through use of such a principled approach in the design, calibration, and analysis of
a computer simulation, a robust in silico tool can be developed which can both further the
understanding of a biological system being explored, and act as a tool for the generation
of hypotheses which can be tested utilizing experimental approaches.
Keywords: agent-based modeling, computational modeling, development, lymphoid tissue inducing cells,
lymphoid tissue organizer cells, Peyer’s patches, sensitivity analysis
INTRODUCTION
The analysis of mice deﬁcient for key transcription fac-
tors (ID2, RORγt), cytokines (IL-7), chemokines (CXCL13,
CCL19/21), TNF superfamily members (LTβ, RANK), RET, adhe-
sion molecules, and associated signaling pathways has led to an
understanding of the detailed cellular and molecular elements that
play a key role in secondary lymphoid tissue development. How-
ever, a reductionist approach focusing on the role of individual
cells types and molecules is limited in the insight it can provide
into how this tissue develops, because it is the complex temporal
interactions between cells and signalingmolecules that dictates the
end result: the formation of the organ.
To further understand the underlying mechanisms in such
systems, mathematical and computational biology is becoming
increasingly prevalent. Such approaches permit the development
of models which aim to provide an interpretation of the under-
lying biological data upon which they are constructed (Guo and
Tay, 2005), and to act as a tool for exploration and development
of new hypotheses which may lead to testable outcomes that can
be examined using traditional experimental approaches (Andrews
et al., 2008). The application of such modeling techniques has per-
mitted the exploration of a range of complex biological systems,
including T cell signaling cascades (Chakraborty and Das, 2010),
autoimmune disease pathology (Read et al., 2009), investigating
cell migration within germinal centers (Figge et al., 2008), emer-
gence of immune memory (Lagreca et al., 2001; Jacob et al., 2004),
and system dynamics under HIV-1 infection (Sieburg et al., 1990;
Stafford et al., 2000). However, the approach has yet to be adopted
in the exploration of immune system development.
Work in this paper examines the application of a structured
methodology that integrates traditional in vivo and ex vivo exper-
imental techniques such as gene knockouts, real-time imaging,
gene expression data sets, and functional ex vivo culture systems,
in the creation of a model that encompasses the dynamics of a
complex system being studied (Figure 1A). The objective is to
demonstrate that a structured process is required in the design of
any computer simulation of a biological process if conﬁdence is
to be retained in the use of that simulation as a scientiﬁc tool.
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FIGURE 1 | (A) Schematic of the modeling process. Data obtained using
experimental biological approaches was used to develop a series of models:
Domain Model – explicitly capturing an abstraction of the biological system;
Platform Model – detailing how the biological system is implemented as a
computer simulation; Simulation Platform – coding the platform model;
Results Model – interpretation of simulation results and relationship to
biological system. Through use of in silico experimental results model new
models and new hypothesis can be developed. (B)To determine if the size
and number of PP that form in mice is stochastic, the relative size and
location of PP from six adult mice was determined.
We then demonstrate how statistical tools that analyze output
from the constructed simulator can be used to predict changes in
cellular behavior under different physiological conditions. These
lead to predictions being made that may be tested within the
laboratory. As Figure 1A demonstrates, this leads to the gener-
ation of an iterative process, where the biological understanding
heavily inﬂuences the development of the model and simulator,
from which results may inﬂuence laboratory investigations, which
may in turn produce results which inform later iterations of model
development.
Any exploration of a biological system, whether this uses tra-
ditional experimental or computational methods, will be open
to a degree of skepticism as the understanding of each underly-
ing detail is incomplete. This is addressed through the making of
assumptions, justiﬁed by available evidence. Thus, the exploration
is focusing on an abstraction of the real system. The abstrac-
tion captured in any computer simulation will be greater than
that examined using traditional laboratory approaches, as it is
intractable to capture all current understanding in a model. It is
critical that this is taken into consideration when judging how
relevant any results are to the biological system under study. For
this reason, it is important that a rigorous process is adopted in the
design of any simulation, where all assumptions and abstractions
are documented and justiﬁed for scrutiny alongside simulation
results, and the link between the underlying biological system
and how this is encoded is fully appreciated by both immunol-
ogists and the modeler. The methodology involved in developing
the model and simulation in our case study utilizes the princi-
pled approach of the CoSMoS (Complex Systems Modeling and
Simulation Infrastructure) process (Andrews et al., 2010), which
Frontiers in Immunology | Inﬂammation July 2012 | Volume 3 | Article 172 | 2
“ﬁmmu-03-00172” — 2012/7/16 — 20:56 — page 3 — #3
Alden et al. Computational modeling of immune development
can be used to create and validate simulations of complex systems.
In this process, the biological system being explored is termed the
domain of interest. Understanding of the functional elements in
the system is captured in a series of models: domain, platform,
simulation, and results. The domain model encapsulates the cur-
rent scientiﬁc understanding for each biological entity within the
model. The platform model speciﬁes how the domain model will
be implemented as a computer simulation. The simulation model
is executable software constructed from the speciﬁcation in the
platform model. The results model is a mapping detailing how the
output from the simulation relates back to the biology. The con-
struction of each model is an important step in the process, with
the aim of ensuring that conﬁdence is retained in the model as a
representation of the system, and that results from the simulation
relate back to the biological system and can be justiﬁed.
As a demonstration of how this approach can be applied,
the role lymphoid tissue inducer and initiator cell populations
(LTi/LTin) have in the development of Peyer’s patches (PP) was
examined. PPs have an essential role in the initiation of adaptive
immune responses to infection within the gastrointestinal tract,
and are comprised of an organized structure of B cell follicles con-
taining follicular dendritic cells (FDC), T cell zone and associated
ﬁbroblastic reticular cells (FRC), surrounded by a mucosal epithe-
lium (Jung et al., 2010). Antigens are transported by specialized
epithelial cells, M cells, to dendritic cells in the FRC, which trig-
gers an adaptive immune response. Pre-natal studies show that an
average of 60 PP develop in the human fetal gut (Cornes, 1965),
and 8–12 in the mouse (Figure 1B), distributed along the gut
length with a large variation in the location, number, and size
of PP between different genetically identical mice, indicating a
stochastic nature to the process.
Peyer’s patches form through a clustering of hematopoietic
and stromal cells on the anti-mesenteric side of the small intes-
tine (Randall et al., 2008). The properties of the key cellular and
molecular components involved in the development process are
well understood (van de Pavert and Mebius, 2010). In the mouse,
migration of hematopoietic LTin and LTi cells into the mid-gut
occurs from embryonic day 14.5. LTin cells express the tyro-
sine kinase receptor RET and initiate the process of PP induction
through an adhesion-dependent chemokine-independent process,
ultimately leading to lymphoid tissue organizer (LTo) cell mat-
uration (Fukuyama and Kiyono, 2007; Veiga-Fernandes et al.,
2007; Patel et al., 2012). Upon LTo triggering, LTi cells inter-
act with Vcam + LTo cells through LTb/LTβ receptor inducing
the production of IL-7, and chemokines CXCL13, CCL19, and
CCL21 (Adachi et al., 1997; Luther et al., 2003). LTi cells express
the corresponding receptors for these chemokines (CXCR5 and
CCR7; Adachi et al., 1997), thus further hematopoietic cells are
attracted to the region through chemotaxis, and retained by adhe-
sion molecules. This promotes further cellular interaction, which
increases the concentration of IL-7, chemokines, and localized
expression of adhesion molecules in the forming cluster. This is a
self-sustaining process, up to a point at E18.5 where, for reasons
not currently understood, further clustering of PPs ceases to occur
(Randall et al., 2008).
In the development of any simulator, it is essential that the ques-
tions it will be used to address are deﬁned prior to its construction,
as this directly affects the choice of modeling strategy. Recent
ex vivo experimental work has focused on the initial 12 h of PP
development, which has revealed that the behavior of LTin/LTi
cells within 50μm of a RET ligand-expressing ARTN soaked
micro-sphere is statistically different to that of cells further away
(Patel et al., 2012). The cellular behavior observed in the ex vivo
culture system is thought to emerge from interactions between
LTin/LTi cells and the LTo cells. In conjunction with the experi-
mental approaches, our model captures the cellular dynamics up
to this time-point, in the hope of generating hypotheses on why,
for each cell, this emergent behavior becomes apparent. Thus,
it is not possible to use a traditional ordinary differential equa-
tion (ODE) modeling strategy, as our focus is at an individual
rather than the population level (Guo and Tay, 2005). In such
cases a multi-agent models is necessary. In this approach, each
biological entity exists as an autonomous object, referred to as an
agent, with associated states and within a speciﬁed spatial envi-
ronment (Forrest and Beauchemin, 2007). These agents interact
with others in the environment through a set of rules that in turn
change the agent’s state. At this level, it is possible to observe entity
behavior or structural formation that emerges through interactions
between agents.
As we are seeking to understand the behavior of each cell
individually, our demonstration of this methodology focuses
on the creation of a multi-agent simulation. Our purpose is
to explore how cellular interactions have led to the emergent
behavior observed. This allows us to create a model at a higher
level of abstraction, removing the need to explicitly model each
individual component involved in the interaction and each under-
lying mechanism. As Germain et al. (2011) note, the focus shifts
from an examination of each individual component part to
that of the higher order behavior and how this emerges from
components which lack the capability to do this alone. This
permits an understanding of how small perturbations in indi-
vidual system components affect the end outcome of the process
(Germain et al., 2011).
With the application of the CoSMoS process (Andrews et al.,
2010), we demonstrate how the set of models is generated and the
underlying biology captured through the use of Uniﬁed Modeling
Language (UML) diagrams. We then describe how the simula-
tor created from these models has been calibrated to reproduce
emergent behaviors that are statistically similar to those observed
ex vivo (Patel et al., 2012), providing a level of conﬁdence that the
simulator is an adequate representation of the real system. The
latter part of this study demonstrates how the simulator can be
used to explore the complex system under examination. Using the
PP simulator, we show how the capacity of the model to replicate
previously published gene knockout and over expression experi-
mental results can be rigorously tested. Using statistical analysis
techniques, including sensitivity analysis techniques, changes in
observed behavior when the model is run under different condi-
tionswasused todetermine the relative role of different parameters
involved in PP development. Speciﬁcally, we focused on the role
chemoattractant molecules have in inﬂuencing cellular behav-
ior and tissue organogenesis, and the time-point at which these
molecules become inﬂuential. Use of these methodologies per-
mits quantiﬁcation of the capacity of simulation to determine
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changes in cellular behaviors and emergent behaviors when quan-
titative changes are applied to each system component, allowing
in silico experimentation with the aim of informing future
laboratory experimentation.
MATERIALS AND METHODS
MODEL DEVELOPMENT
To develop a computer simulation of lymphoid tissue formation,
an agent-based approach to complex systems modeling was uti-
lized, and through the application of the CoSMoS process a series
of models created (Andrews et al., 2010).
DOMAIN MODEL
The domain model (Figure 2) focuses on modeling the biological
system by encapsulating current scientiﬁc understanding of cel-
lular behavior. Thus, this is a purely biological model, ensuring
isolation between the understanding of the system to be captured,
and how this translates into computer code. This is important as at
this point the details of how the simulation is to be implemented
are not of concern, and may distract from the speciﬁc model-
ing of the biological system. The domain features the component
parts of the system which will be included in the in silico model
including the cell types, the factors which inﬂuence cell behav-
ior (e.g., chemokines, adhesion factors) and a description of the
environment inwhich interactions take place (e.g., the fetal intesti-
nal tract). Any abstractions and necessary assumptions made are
clearly documented for later scrutiny (Tables 1–3).
State diagrams
Each of the key cell types identiﬁed in the literature is repre-
sented explicitly in the domain model. For each cell type, the states
(observed behaviors or gene expression proﬁle) that the cell might
exist in and the interaction(s) that must take place for that cell to
change state were examined. For example, an LTo (stromal) cell
(Figure 2C) initiates in the model as an undifferentiated stromal
cell until LTβ receptor activation, upon which the LTo cell induces
expression of cytokines, chemokines, and adhesion factors critical
for PP development. Such descriptions are documented through
the use of state diagrams (Figure 2), a documentation method
closely related to the notation included within UML and widely
used in software engineering (Bersini and Carneiro, 2006; Read
et al., 2009). Through creating this model, parameters are identi-
ﬁed and recorded. Some of these parameters have known values
which have been determined experimentally, whereas the values
of others are currently unknown.
Activity diagram
A further UML diagram, an activity diagram, is utilized to specify
how the cells identiﬁed in the state diagrams interact (Figure 3). It
is through these interactions that the observedbehavior is expected
to emerge. Thus, in this model, it is the interactions between cells
that causes statistically signiﬁcant changes to LTi/LTin cell velocity
and displacement.
PLATFORM MODEL
Utilizing the domain model the implementation of the computer
simulation is documented using a platform model. This speciﬁ-
cally details how the individual cells, the model environment and
interactions described in the domain model will be implemented
in the computer simulation (Figure 4). In the platform, the inter-
actions that lead to state changes are examined and translated
into a form which can be captured in computer code (the sim-
ulator). Further parameters are identiﬁed during this process
and described, and as in the domain model, the numerical val-
ues of some parameters are unknown. These parameters capture
the behavior of component parts such as adhesion molecules,
cytokines, and chemokines. Despite the importance of these fac-
tors, the number of molecules expressed by the different cell
types, the level of chemokine expression required to induce cellu-
lar chemotaxis and the diffusion distribution of chemokines and
cytokines in the localized environment all are currently unknown.
Thus further assumptions are made based on known biology and
documented for scrutiny alongside simulation results (Tables 1–3;
Figures 5 and 6). Critical to the modeling process, emergent
behavior speciﬁed in the domain model is entirely removed from
the platform model. Biologically observed behavior must emerge
through interactions between components and not be encoded
into the model, as this invalidates the simulator as a predictive
experimental tool.
One of the strengths of agent-based simulation is the ability to
consider spatial elements of the biological environment. Thus, it
is critical to accurately represent the fetal intestine tract in which
our agents interact, andunderstandhow this environment changes
during the time-frame of the simulation. Images were taken of the
developing mid-gut from twelve embryos, six at E14.5 and six
at E15.5, using stereomicroscopy (Zeiss). Measurements of the
length and circumference of each were then taken using ImageJ
(Fiji). Taking measurements at different time-points ensures the
dynamic nature of the developing tract (model environment) was
captured. Using these measurements, and known cell sizes (Veiga-
Fernandes et al., 2007) a virtual environment was created which
accurately represents that seen ex vivo (Figure 7), and a scale
set where 1 pixel in our graphical simulation will represent four
microns. The platform model also speciﬁes how the user interacts
with the simulator (e.g., graphical interface representing the envi-
ronment and the control panel), and speciﬁes how data can be
extracted for further analysis (Andrews et al., 2011; Table 4).
SIMULATOR
The computer simulation was created from the speciﬁcation in
the platform model. The Java-based MASON simulation envi-
ronment, a cross-platform toolkit for the creation of multi-agent
simulations was used (Luke, 2005). Each agent (cell) type is cre-
ated as a Java class, with state transitions encoded to match those
speciﬁed on the platform model. MASON simulations work in
steps, where each active agent performs the behavior determined
by its current state within each step. Such a feature allows for the
inclusion of time in the simulation. By default, one simulation
time-step represents 1 min of developmental time. A copy of the
Java code for the simulation and the simulator is accessible online
at http://www.cs.york.ac.uk/immunesims/frontiers.
SIMULATOR CALIBRATION USING EXPERIMENTAL DATA
To identify values for parameters identiﬁed in the domain and
platform models, numerical values were determined from the
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Parameter
Probability stable bind occurs on contact
Percentage of LTo cells expressing RET Ligand
Percentage of RET Ligand Cells that are non-stromal
Hours Immature LTo remains active
Lto Division Time
Hours RET Ligands Expressed
LTin / Lti Cell size
LTin / Lti Cell Speed Lower Bound
LTin / Lti Cell Speed Upper Bound
LTin Input Time
Lti Input Delay Time
Lti Input Time
Chemokine Threshold
Lto Cell Size
thresholdBindProbability
percentStromalRETLigands
percentLTinLTiRETLigands
imLToActiveTime
IToDivisionTime
numHoursRETLigandActive
HCellDiameter
cellSpeedLowBound
cellSpeedUpBound
ITinInputTime
ITiInputDelayTime
ITiInputTime
chemoThreshold
LtoDiameter
50%
Unknown
Unknown
72 hours
12 hours
72 hours
8 μm
3.8 μm / min
8.8 μm / min
72 hours
0 hours
72 hours
Unknown
24 μm
χ
θ
Η
ϖ
Ν
ρ
τ
σ
ω
ξ
ε
γ
η
ϕ
Simulation Domain Value
L To
(Domain)
No Expression of RET-Ligand1
If distance to LTin Cell σ/2 + T/2 (cell in contact)
AND
Bind between cells is sufficient (>X)
AND 
LTo can still differentiate (time elapsed < ω and ρ)
Upregulation of Adhesion Molecules 2,4
Upregulation of Chemokines 2,3,4
Mature LTo 4
1: Adhesion factor expression for LTo cells in this state is detailed in Figure 6
2: Upregulation of adhesion factors for cells in this state is detailed in Figure 6
3: chemokine expresion and upregulation is detailed in Figure 5
4: While in this state, the cell will divide when it has been active for a time period specified in N
If distance to LTi Cell σ/2 + T/2 (cell in contact)
AND
Bind between cells is sufficient (>X)
AND developmental time elapsed < ρ
Adhesion Molecule Levels at peak
AND
Chemokine Expression at peak
Expression of RET-Ligand1
If cell not within percentage θ of
cells that express RET Ligand
If cell within percentage θ of
cells that express RET Ligand
L Ti
(Domain) Migration into intestine tract
between timepoints stated by γ and η
LTo adhesion level insufficient
to prolong contact OR cell moves
away for other reason
Contact Cell is an 
LTo Cell
AND
Bind between cells is
sufficient (>X)
AND
LTo adhesion level 
insufficient to
prolong contact
Contact Cell is an LTo Cell
AND
Bind between cells is sufficient (>X)
AND
LTo adhesion level  sufficient
to prolong contact
1: Cell Speed falls somewhere between a lower bound specified by ω and an upper bound specified by ξ
Random movement on tract surface1
Response to Chemokine Level in Local Environment
Contact Cell is not
an LTo
OR
Bind between cell
& LTo cell is
insufficient (< X)
Distance between
cell and RET
Ligand Expressing Cell
< σ/2 + T/2 
Local Chemokine Level < ϕ
Prolonged surface Contact (Adhesion Effect)
Contact with Cell Expressing RET Ligand
Local Chemokine Level > ϕ
A
B
C
D
L Tin
(Domain)
LTo adhesion level insufficient to
prolong contact
OR cell moves away for other reasonContact Cell is an LTo Cell
AND
Bind between cells is
sufficient (>X)
AND
LTo adhesion level
insufficient to prolong contact
Contact Cell is an LTo Cell
AND
Bind between cells is sufficient (>X)
AND
LTo adhesion level sufficient to prolong contact
Contact Cell is not an
LTo Cell
OR
Contact Cell is an
LTo
AND
Bind between cells
is insufficient (<X)
Distance
between LTin
and RET Ligand
Expressing Cell
< σ/2 + T/2 
Contact with RET Ligand expressing Cell
Localised movement around LTo mediated by adhesion
1: Cell Speed falls somewhere between a lower bound specified by ω and an upper bound specified by ξ
Random movement on tract surface1
Migration into intestine tract
between shart of simulation and endpoint set by ε
FIGURE 2 |The domain model captures an abstraction of the biological
domain.The state diagrams, created using a modiﬁed version of Uniﬁed
Modeling language, provide a description of the states in which the identiﬁed
agents (cell type) may exist within (the boxes), and the biological event that
must take place for that agent to transition into the next state (the arrow).
This does not contain any simulation-speciﬁc detail. (A) LTin cell, (B) LTi cell,
(C) LTo cell, and (D) biological parameters identiﬁed in the creation of the
domain model.
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Table 1 | LTin assumptions.
Agent State Model Assumptions
LTin Random movement on tract surface Domain There is no attractive inﬂuence on an LTin cell – any contact with RET ligand-expressing
cells will occur randomly
Platform Each cell is assigned a speed between the lower limit set by parameter ω and upper limit
set by parameter ξ. This is chosen randomly from a Gaussian random number generator.
Contact with RET ligand-expressing cell Domain For lymphotoxin signaling to occur, the bind between the two cells must be of sufﬁcient
strength. If the bind afﬁnity is sufﬁcient, we assume that cell signaling always occurs.
If contact is with a cell expressing RET ligand yet not an LTo, and a stable bind occurs,
the cells will bind brieﬂy but no signaling occurs
Platform Whether LTin and LTo cells bind will be determined by a probability function. If a chosen
probability is > parameter γ then a stable bind is formed
Localized movement around LTo
mediated by adhesion
Domain An LTin cell will remain in contact with an LTo cell if there is a sufﬁcient expression level
of adhesion factors
As expression level increases, the LTin cell is more likely to remain in contact
Though there may be sufﬁcient expression level of adhesion factors, there is still a
possibility that the LTin cell may move away from the LTo
Though the cell remains in contact with the LTo, LT signaling and up-regulation of adhesion
factors and chemokines only occurs on initial contact
Platform LTin cell will remain in close contact with the LTo cell making small movements around it.
When an LTin cell is held in direct contact to an LTo cell, the cell will remain in its
current location.
Prolonged adhesion is decided through use of a probability function. Diagram in Figure 6
details how adhesion has been captured in the Platform Model.
Other assumptions Domain LTin cells migrate into the tract throughout the whole period being modeled.
All LTin cells are the same size, 8 μm
Platform Through FACS staining we are aware of the number of LTin cells that should be present
at E15.5 in development. A linear input rate is used to ensure this is reached. This
rate remains constant throughout the simulated period
The environment is modeled as a 2-D plane on which all movement and interactions occur
(see environment in Platform Model). Should an LTin cell leave the left or right of the
screen, this cell will be removed from the simulation
List of assumptions made at both domain and platform model level concerning the behavior of and interactions with an LTin cell.
literature and unpublished experimental data However, obtaining
a numerical value for many parameters is not currently possible
due to technical experimental limitations. Calibration is the pro-
cess by which values are obtained for any parameters for which a
numerical value is unknown. The objective is to ensure that the
simulator produces cellular behavior that is statistically similar to
that observed in previously published studies (Veiga-Fernandes
et al., 2007; Patel et al., 2012).
The simulation has been calibrated against the observed behav-
ior of cells close to a PP versus those observed prior to patch for-
mation (Patel et al., 2012). In this case, there are six parameters for
which the value is uncertain: (a) probability at which an LTin/LTi
cell will form a stable bind with an LTo cell upon contact, (b)
the initial level of chemokine expression upon LTo differentiation,
(c) the limit on chemokine expression level, (d) the level of
chemokine required in the environment to induce LTi cell chemo-
taxis (e) the level at which adhesion factors are expressed with each
stable contact, and (f) the probability that the level of adhesion fac-
tors expressed on the surface of an LTo cell will restrain LTin/LTi
cell movement. Thus, values for these parameters needed to be
established that lead to simulation outcomes of cellular behavior
that does not differ from those observed ex vivo. To test for statis-
tical similarity between the distributions seen experimentally and
those observed in simulation, the non-parametricMann–Whitney
U test has been used, as the results will not be normally dis-
tributed. Values for all six parameters were established through a
structured trial and error approach, and lead to cellular behavior
that is statistically similar to that observed (Patel et al., 2012).
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Table 2 | LTi assumptions.
Agent State Model Assumptions
LTi Random movement on tract surface Domain Cells move randomly until the level of chemokine expression in the vicinity is above
a threshold
Platform To ascertain chemokine level, the simulator will calculate the expression level in each
“gridsquare” around the cell (see Modeling Chemokines for more information).
If none of these values is above ϕ, the cell moves randomly
Response to chemokine level in local
environment
Domain Three chemokines are known to play a part in the process – CXCL13, CCL19, and CCL21.
However as an abstraction we will assume these can be modeled as a single
chemokine (see Modeling Chemokines)
IL-7, which could stimulate IL-7 receptor signaling and regulate chemokine receptor
expression levels of LTi cells, has not been included in the model.
The assumption will be made that there is always sufﬁcient IL-7 present for chemokine
receptor expression to be upregulated
There is always a small chance that the cell may not respond to the level of chemokine,
although the expression level may be greater than ϕ
Platform Chemokine expression is modeled using an inverse sigmoid curve (see Modeling
Chemokines).
As some stochasticity must remain, the chance that the cell will move in the direction
of the strongest level is determined by probability function
Contact with RET ligand-expressing
cell
Domain For lymphotoxin signaling to occur, the bind between the two cells must be of sufﬁcient
strength. If the bind afﬁnity is sufﬁcient, we assume that cell signaling always occurs.
If contact is with a cell expressing RET ligand yet not an LTo, and a stable bind occurs,
the cells will bind brieﬂy but no signaling occurs
Platform Whether LTi and LTo cells bind will be determined by a probability function. If a chosen
probability is > parameter γ then a stable bind is formed
Prolonged surface contact
(adhesion effect)
Domain An LTi cell will remain in contact with an LTo cell if there is a sufﬁcient expression level
of adhesion factors
As expression level increases, the LTi cell is more likely to remain in contact
Though there may be sufﬁcient expression level of adhesion factors, there is still a
possibility that the LTi cell may move away from the LTo
Though the cell remains in contact with the LTo, LT signaling and up-regulation of
adhesion factors and chemokines only occurs on initial contact
Platform The LTi cell would remain in close contact with the LTo cell making small movements
around it. When an LTin cell is held in contact to an LTo cell, the cell will remain in its
current location.
Prolonged adhesion is decided through use of a probability function. See Figure 6 which
details how adhesion has been captured in the Platform Model (modeling adhesion)
Other assumptions Domain LTi cells migrate into the tract throughout the whole simulated period
All LTi cells are the same size – 8 μm
Platform Through FACS staining we have determined the number of LTi cells that should be present
in the mid-gut at E15.5 in development. A linear input rate is used to ensure this is reached.
This rate remains constant throughout the simulated period
The environment is modeled as a 2D plane on which all movement and interactions occur
(see Modeling the Environment in Platform Model). Should an LTin cell leave the left or
right of the screen, this cell will be removed from the simulation.
List of assumptions made at both domain and platform model level concerning the behavior of and interactions with an LTi cell.
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Table 3 | LTo assumptions.
Agent State Model Assumptions
LTo No expression of RET ligand Domain Although we are aware that 20% of the intestine tract contains stromal cells, we assume
only a percentage of these have the potential to become patches.
Platform Where only a percentage of LTo cells are active, all are still placed on the intestine tract,
but interactions only occur with LTo cells which have the potential to become patches
(that express RET ligand).
Expression of RET ligand Domain Cell will remain active throughout the time period, irrespective of whether the cell changes
state or not
Platform All LTo cells which express RET ligand have the potential to express adhesion factors and
chemokines (thus form patches)
Upregulation of adhesion molecules Domain Adhesion molecules are up-regulated with every contact where the strength of the bind is
sufﬁcient (see Modeling Adhesion)
Up-regulation only occurs on initial contact with the cell – prolonged contact due to adhesion
does not lead to further up-regulation
Cells in this state will divide after a set number of hours
Platform Expression of adhesion factors does not degrade over time
With each stable contact, a counter representing adhesion factor expression is increased.
This determines the strength of adhesion and probability the cell will remain in contact.
(see Modeling Adhesion).
Upregulation of chemokines Domain Chemokines are up-regulated with each LTi/LTo contact where the strength of the bind is
sufﬁcient (see Modeling Chemokines)
Up-regulation only occurs on initial contact with the cell – prolonged contact due to adhesion
does not lead to further up-regulation
Cells in this state will divide after a set number of hours
Platform Chemokine expression does not degrade over time
With each stable contact, a counter representing chemokine expression is increased.
This determines the distance over which the chemokine has an effect.
(see Modeling Chemokines)
Mature LTo Domain
Platform Both adhesion molecules and chemokines must have reached their peak of expression
to reach this state
Other assumptions: Domain It is assumed that other pathways, such as the NF-κB pathway, are always activated
upon stable contact, and thus not explicitly modeled
List of assumptions made at both domain and platform model concerning the behavior of and interactions with an LTo cell.
REDUCING UNCERTAINTY IN SIMULATION RESULTS
Prior to performing any analysis of simulation results, it is impor-
tant to establish the number of replicate runs necessary (n) to
produce a robust representative result that reﬂects the analysis
being performed, and is not heavily inﬂuenced by uncertainty
arising from inherent stochasticity within the simulation. This
calculation is a pre-requisite in understanding the simulator’s sen-
sitivity to parameter perturbation. Such a judgment cannot be
made if the effect of the underlying inherent stochasticity is not
appreciated. This was achieved using a technique developed by
Read et al. (2012), which examines the relationship between the
number of runs performed and the effect of such uncertainty for
a given set of parameters, establishing an n to use in all subsequent
analyses.
To establish n, a number of replicate run sizes were chosen
(1, 5, 50, 100, 300, 500, and 800). Taking the sample size of ﬁve
as an example, twenty simulation result sets were obtained, with
each of the twenty sets containing the results from ﬁve simulation
runs. From the results of each simulation run, medians are cal-
culated for each of the cell behavior output measures captured.
These are collated to form a set of medians for each of the 20
subsets. The medians from each set are compared to the ﬁrst set
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FIGURE 3 | Activity diagram of domain model representing the low-level interactions between the cells (LTin, LTi, LTo cells) which lead to the
formation of PP. Cellular behaviors are described in boxes, decisions points indicated by diamonds and lines. Arrows indicate potential changes to
cellular behavior.
using theVargha–DelaneyA-Test (Vargha andDelaney, 2000). The
test compares the two distributions and returns a value between 0
and 1.0, with a result of 0.5 indicating no difference, and results
above 0.71 and below 0.29 indicating a statistically signiﬁcant dif-
ference between the two sets. To achieve a representative result,
there should be no statistical difference in all 20 comparisons.
In this case, this was achieved when each of the 20 subsets con-
tained the results from 500 simulation runs (Figure 8). Therefore,
n =500 was used for the remaining analyses.
IN SILICO EXPERIMENTATION
Simulations have been performed to test the robustness of the
model to determine if PP emerge replicating gene knockout and
over expression experiments published in the literature and to
determine if key features of the biology are observed in the in
silico model. Comparison with the observed biology was made
by comparing snapshots of the simulated environment post sim-
ulation run to observed phenotypes using antibody staining of
LTi and LTo cells. To simulate gene knockouts, Boolean parame-
ters indicating the inclusion of the relevant component are set to
false. To simulate changes to level of expression, values for relevant
parameters were adjusted. The simulation has been run under the
following conditions from the established literature (Figure 9):
(Figure 9A) Normal parameter setting (control wild type mice),
(Figure 9B) RET deﬁciency (RET−/− mice; Veiga-Fernandes
et al., 2007), (Figure 9C) chemokine knockout (CXCL13−/−,
CCL19/21−/− mice; Luther et al., 2003), (Figure 9D) no LTin
cells (RORγ−/− mice; Eberl et al., 2004), (Figure 9E) doubling
number of LTi cells (IL-7Tg mice; Meier et al., 2007). Consistent
with established results no PP form in either RET, chemokine
or LTi deﬁcient mice (Figures 9B–D). In mice with increased
numbers of LTi cells in the simulation (Figure 9E), more, larger
PPs were observed to develop consistent with the published
results.
PARAMETER EXPLORATION IN THE MODEL
Through experimentation, literature research, and calibration, a
set of parameter values has been established from which the simu-
lator reproduces the emergent cellular behavior observed ex vivo.
However, it is important to establish how sensitive the simulator
output is to alteration in these values. Uncertainty and sensitivity
analysis techniques can be used to quantify the effect perturbing
parameter values has on simulator response, providing an insight
into the sensitivity of both known biological parameter values and
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FIGURE 4 |The Platform model details how the states and interactions
captured in the domain model are coded into the simulation.The
expected behavior, which emerges from interactions between components
in the system, is speciﬁcally not present in the platform model. Behavior
emerges from the simulation and are not coded into the simulation. In the
platform model, how each cell behaves and how interactions are encoded
is detailed. As this includes a variety of factors from the domain model a
number of assumptions are made and documented. (A) LTin cell, (B) LTi cell,
(C) LTo cell, and (D) additional simulation parameters identiﬁed in the creation
of the platform model.
parameters for which a value has been established through calibra-
tion. In this case we consider the inherent epistemic uncertainty
arising from parameters in the latter category, where a value is not
currently known, and demonstrate statistical techniques that can
be used to quantify this uncertainty. However, a full exploration
of the experimentally veriﬁed parameters could also be elucidated
using the same techniques.
Using the calibrated simulator, the impact on cell behavior
has been investigated when the chemokine parameters are mod-
iﬁed. These parameters are: the threshold at which chemokine
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FIGURE 5 | Description of how chemokines are included in the platform model.This details mechanism of chemokine diffusion in the model from the LTo
cell, and how the direction of LTi cell movement is based on a calculation of local chemokine levels.
expression in the environment begins to inﬂuence cell migration
(chemoThreshold); the level of chemokine expressed with each
LTi/LTo contact; and the distance from the LTo cell over which the
chemokine can have an effect (set by parameters chemoLowerLin-
earAdjust and chemoUpperLinearAdjust, detailed in Figure 5).
We also examine the effect of changing the parameter which spec-
iﬁes the probability a stable bind occurs where a hematopoietic cell
(LTin/LTi) comes into contact with a stromal cell (LTo) (threshold-
BindProbability). Impact on simulation response was determined
using two techniques, one-a-time analysis and Latin hypercube
sampling (LHS) and analysis. In one-a-time analysis, the subset of
simulation parameters is examined to determine how robust the
simulation is to a change in input (Read et al., 2012). Taking each
in turn, the parameter is perturbed within a set range of values,
with all other parameters remaining constant. For each parameter
value, 500 simulation runs were performed as established through
robustness analysis. The median of each cell behavior measure
is calculated for the 500 runs, producing a median distribution
set for each parameter value. This set of medians is compared to
that gained from 500 runs of the baseline simulation, using the
Vargha–Delaney A-Test (Vargha and Delaney, 2000). This deter-
mines if a change in the value of that particular component has
www.frontiersin.org July 2012 | Volume 3 | Article 172 | 11
“ﬁmmu-03-00172” — 2012/7/16 — 20:56 — page 12 — #12
Alden et al. Computational modeling of immune development
FIGURE 6 | Description of how the adhesion factors are included in the platform model.This details how the LTo cell increases adhesion factor expression
with each stable contact and the probability that a LTi or LTin cell remains in prolonged contact with an LTo cell is determined in the simulator.
led to behavior which is signiﬁcantly different to that seen in the
calibrated result.
Latinhypercube sampling and analysis, a global sensitivity anal-
ysis technique, has been performed in an attempt to identify any
compound affects which become apparent when two or more of
the components are varied simultaneously (Marino et al., 2008;
Read et al., 2012). A range of potential values has been set for each
parameter of interest, and the parameter space sampled using a
LHS approach (Saltelli et al., 2000). LHS was used to produce
500 parameter value sets, with the value of each parameter falling
within the set range. For each set, the simulation was run 500
times and the relevant cell behavior medians calculated. Taking
each parameter of interest in turn, the sample sets were ordered
by the value assigned to that parameter. A scatter plot was then
generated, for each cell behavior measure, showing the parameter
value in that run against the simulation result. This gives a visual
representation of any correlation between the value of that cell
behavior measure and the value assigned to that parameter. To
gain a statistical indication of an existing correlation, the Partial
Rank Correlation Coefﬁcient was also calculated.
DETERMINING WHEN A PARAMETER BECOMES INFLUENTIAL
IN THE SIMULATION
To analyze the time-point at which a factor in the model begins
to have an inﬂuence on the emergent behavior, the point at which
the chemokine parameter value has a notable effect on cellular
behavior (LTi cells away from a forming cluster) was determined.
The simulation was run to simulate 48 h in PP development, with
LTi cell behavior tracked for an hour at 12 h intervals. Five hundred
simulation runs were performed, with medians recorded for each
cell tracking measure for the respective run. The median results
for hours 24, 36, and 48 were then compared with those from
the calibrated baseline (12 h) using the Vargha–Delaney A-Test
(Vargha and Delaney, 2000), to determine if there is a signiﬁcant
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FIGURE 7 | Description of how the simulation environment relates back to that found in vivo.
difference in cell behavior over time. All statistical analysis was
performed using R.
RESULTS
EXPLORING THE SIMULATION COMPONENTS THROUGH
SENSITIVITY ANALYSIS
To demonstrate the use of sensitivity analysis techniques in explo-
ration of the model, the values of the chemokine parameters,
where the values are uncertain, were perturbed and the effect on
the overall result analyzed.
ONE-A-TIME ANALYSIS
One-a-time analysis was used to determine the effect each param-
eter has on the cell behavior captured in the model (Figure 10).
This provides an indication of how robust the simulation is to
changes in parameter value, and which parameters have the great-
est impact on cell behavior. To determine the effect of a parameter
value perturbation, the simulation results for each value assigned
to that parameter have been compared against simulation results
known to be statistically similar to cell behavior seen ex vivo
using the Vargha–Delaney A-Test (Vargha and Delaney, 2000).
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Table 4 | Additional platform model considerations.
Additional platform model considerations
Simulation
interface
Graphical user interface:
• Enabled with use of MASONToolkit
• Environment and cell movement displayed in
MASON window, settings can be varied on
simulation control console
Non-GUI simulator:
• Interaction via XML parameter ﬁle read by
simulator when started
Instrumentation Simulation results output as CSV ﬁles:
• Tracking results: cells in vicinity of LTo cell
• Tracking results: cells >50 μm from LTo cell
• Cluster size summary
Images:
• Screenshots every time-step during tracking
(for time lapse movie generation)
• Screenshots at every 12 h time-point
• Screenshots at end of simulation
Quantifying data Stored by simulation:
• Cell position (x, y )
• Position when tracking commenced
• Position when tracking time elapsed
• Distance covered in tracking period
Calculated by simulation:
• Cell track length
• Cell velocity
• Cell displacement
• Cell displacement rate
• Cell meandering index
Above ﬁve can then be compared to the measures
gained in ex vivo experimentation
List of simulation design considerations included within the platform model.
These add the ability to interact with the simulator, to state how simulation out-
put will be generated, and list the quantifying data which will be recorded and
output for further analysis.
This analysis indicates that perturbing the expression and thresh-
old level of chemokines (Figures 10A–C) at an early time-point
(initiation of patch formation) has no appreciable effect on the
behavior of cells in the vicinity of a forming patch. All potential
values for the parameter chemoThreshold, which controls a cells
response to a level of chemokine, have been explored, through
never responding to presence within the environment to always
responding. Although the full range has been examined, there is
no signiﬁcant change in cell behavior for any value in compari-
son to calibration results. Thus, early in PP formation the model
predicts that chemokines are unlikely to be the key force driving
the patch formation.
LATIN HYPERCUBE SAMPLING AND ANALYSIS
In contrast to one-a-time analysis, LHS perturbs the values of
all parameters in the subset simultaneously. Using this approach,
any compound effects between parameters which do not become
apparent through perturbing each individually can be identiﬁed.
Analysis of these parameters (Figure 11) at the earliest phase of
patch formation (12–13 h) again indicates that the chemokine
parameter values are not inﬂuential at this phase in PP develop-
ment. LHS analysis of the threshold value at which a chemokine
begins to affect the velocity of cells close to a developing PP shows
no trend in the simulation (Figure 11A). This is apparent both
visually and from the calculated Partial Rank Correlation Coefﬁ-
cient (PRCC) values (in the header of each graph). The PRCC
value gives an indication of an existing correlation between a
change in output measure with a change in the input measure.
However, a small trend does become apparent for the displace-
ment outputmeasure when the threshold value is set to its extreme
value, where a cell always responds to any level of chemokine in
the environment.
INVESTIGATING WHEN A COMPONENT BECOMES
INFLUENTIAL
Chemokines have been shown to have an essential role both
in vivo (Luther et al., 2003) and in silico (Figure 9C), however
using both one-a-time and LHS analysis the parameter values
chemoThreshold, chemoLowerLinearAdjust, and chemoUpper-
LinearAdjust were predicted not to have a signiﬁcant affect in
simulation outcome (Figures 8A and 10A). Thus to determine
if and when these parameters effect cellular behavior, the sim-
ulator for was run for 48 h of simulated time (Figure 12). For
each time-point, 500 sets of cell tracking data were obtained
(500 runs of the simulation) with each containing a minimum
of 30 tracked cells. The resultant distribution of the 500 medi-
ans for each of the 24, 36, and 48 h time-points was compared
to that generated at the 12 h time-point (the calibrated baseline).
Our analysis predicts that these parameters do not start to sig-
niﬁcantly change the behavior of cells until after 36 h into the
simulation, a ﬁnding that can possibly be tested on a biological
set-up.
DISCUSSION
Agent-based modeling is an important methodology for under-
standing complex biological systems. The ability to model time-
variant stochastic systems, coupled with the environment in which
the biological event occurs makes this approach highly applicable
to modeling cellular function and interactions in lymphoid tissue
development and function. This paper has described the process
involved for the development of a robust simulation model, the
application of key principles from systems engineering to translate
biological understanding (the domain) into an unbiased simula-
tor where key aspects of PP formation emerge from the model.
Critically, the simulation has shown that the model faithfully
recapitulates the biology leading to the stochastic formation of
PPs. In fact for simulations of mice deﬁcient in known regula-
tory factors of PP development (chemokines, RET tyrosine kinase,
and adhesion molecules) the expected “phenotype” was observed
in silico.
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FIGURE 8 | Robustness analysis to determine the number of replicate
simulation runs necessary to produce a robust, representative result.The
twenty result subsets are listed along the x axis, with the Vargha–Delaney
A-Test score on the y axis. The subsets are labeled as “dummy parameter”
sets as no parameters are being changed. The plot shows the comparison
scores for both cell behavior output measures: cell velocity and cell
displacement. Each of the 20 result subsets contains a number of simulation
run results. From these, a set of results is generated containing the median of
each cell output measure for each simulation run in the set. Each set of
medians is then compared to the ﬁrst set using the Vargha–Delaney A-Test.
This ﬁgure shows the results for four of the sample sizes used. (A) 5, (B) 50,
(C) 100, and (D) 500.
CREATING A FRAMEWORK TO UTILIZE SIMULATION MODELING
TO UNDERSTANDING IMMUNE SYSTEM FUNCTION AND
DEVELOPMENT
The inherent complexity and interconnectivity of in vivo phys-
iology has led us to develop computational simulations of an
immunological process to provide novel insights into that pro-
cess. Although this methodology is well established in physics,
chemistry, ecology, and structural biology, the use of compu-
tational approaches has been limited due to the highly stochas-
tic and interconnected nature of immune responses. Although
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FIGURE 9 | Images of typical simulation runs at a time-point
representing 72 h of PP development. Conditions have been created which
replicate known phenotypes from mice: (A) Control, (B) RET−/− LTin cells
(simulated knockout), (C) Chemokine deﬁciency (simulated CXCL13,
CCL19/21 knockout), (D) LTin-deﬁcient mice (simulated RORγ−/−mice),
(E) doubling number of LTi cells (IL-7Tg mice).
mathematical ODE models are a potent methodology for under-
standing how populations behave, they are limited in their ability
to describe complex phenomena, like lymphoid tissue formation,
that emerges during immune development through interactions
between individual cells. Thus, we have demonstrated a simpli-
ﬁed non-mathematical approach that allows easy translation of
the biology into a set of models that are easy to understand and
interact with. Using these models in the creation of the simulator
ensures the production of a tool where the scope and encapsu-
lation of the biological understanding is clear, thus simulation
results canprovidemeaningful insight intomolecularmechanisms
driving the biological process. The CoSMoS modeling process
(Andrews et al., 2010) has been developed to make computa-
tional simulation accessible through breaking down the process
into well documented steps that permit immunologists to develop
models, understand how the agents interact and query the valid-
ity of the model. In the ﬁrst step of the process the biological
entity can be described using UML to create a domain model that
accurately represents the biological system and the interactions
between the different cell types and the environment during the
process: in the PP domain model we succinctly document the
key cell types (LTi, LTin, LTo), the different cellular states dur-
ing PP development, and cellular interactions that are known to
drive PP formation. Using the domain model, a platform model
was created, again using UML, to represent the modeling envi-
ronment and detail how individual cells interact and change state
within the model environment. This platform model used to spec-
ify the agent-based computational model which is implemented in
the Java programming language. By creating a separate model on
which the simulation is generated, crucially cellular behaviors that
must emerge through interactions between agents in themodel are
removed, and not coded into the model. By using an open source
Java-based modeling environment and open source statistical
tools, the technological barriers to create and utilize a compu-
tational model have been kept to a minimum. The PP simulator,
the documented Java source code, all tools created for the visual-
ization of PP formation and statistical analysis of the model are
freely available for download from the web (http://www.cs.york.
ac.uk/immunesims/frontiers). Making the model freely avail-
able makes it possible for immunologists to engage with the
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FIGURE 10 | Robustness analysis of simulation use a one-
parameter-at-a-time approach, which perturbs the value of just one
parameter, leaving the remaining values constant in the simulation.
This provides an indication of the effect perturbing each individual parameter
has on simulation output. Cell behavior was compared to the calibrated
baseline results using the Vargha–Delaney A-Test, which determines if
two distributions statistically differ. Plots of A test score vs parameter
values was plotted with the change from observed cellular behavior
varies signiﬁcantly from the simulation. (A) Chemokine threshold,
(B) initial expression level of chemokine, (C) maximum expression level
of chemokine, (D) probability of stable bind when two cells are in contact.
N = 500.
model for their own research and provide critical feedback
on the future iterations of the simulator, as demonstrated in
Figure 1A. Utilizing this framework it is possible to rapidly
develop meaningful computational simulations of immunological
processes.
PAIRING EXPERIMENTATION AND COMPUTATIONAL
MODELING
Innate lymphoid cells have recently been shown to have essen-
tial roles in both the development of lymphoid tissue and
normal lymphoid and epithelial tissue function. Bioinformatics
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FIGURE 11 | Parameter analysis, using a Latin hypercube approach, to
determine the influence of parameters on simulation output measures.
(A) chemokine threshold vs. velocity, (B) chemokine threshold vs
displacement, (C) probability of stable bind when two cells are in contact vs
velocity, and (D) probability of stable bind when two cells are in contact vs
displacement. N = 500.
approaches have provided novel insights into pathways that regu-
late cellular function; however they are limited in their capacity
to understand how intracellular signals drive process during a
complex stochastic process. Although knockout mice provide key
insights to the functional requirement for particular pathways they
often fail to capture how, when and where the pathways regulate
the biological process. Although chemokines have been previously
been shown to be essential in the formation of patches (veriﬁed in
the model), the timing of chemokine mediated effects during PP
formation are unknown. Utilizing the PP simulator and statistical
analysis techniques, the parameters that control chemokine func-
tion in the model have been shown, surprisingly, to have no effect
during early stages of PPdevelopment. By sampling themodel over
time it was possible to show that the effect of chemokines on LTi
cell behavior was only found to be statistically signiﬁcant 36 h into
the simulation. This is consistent with biological observations that
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FIGURE 12 | Computer simulation to predict when chemokine
expression level has a significant effect on cell behavior. For 24, 36, and
48 h time-points, datasets have been generated which record the
displacement of each cell in the system for a sixty minute period after that
time-point. Each set of results is then compared to the simulation baseline
cell behavior at 12 h using the Vargha–Delaney A-Test.
the behavior of LTi cells at E15.5, 24 h post initiation of LTi/LTin
inﬁltration into the fetal mid-gut, the movement of all observed
cells was a normal random walk (Veiga-Fernandes et al., 2007).
Through using simulation we have shown that predictive models
can be used to integrate mechanisms of when signaling path-
ways start to affect the outcome of stochastic processes, providing
new insights into mechanisms driving immune development and
function.
INSIGHTS THAT IN SILICO MODEL MIGHT PROVIDE TO
UNDERSTANDING PP DEVELOPMENT
The utilization of a calibrated and veriﬁed computational model
where behaviors emerge provides the potential to use simulation
results to generate new hypothesis that can then be tested in vivo.
In particular, the simulator provides a unique tool to determine
potential factors and molecular mechanisms driving the initiation
of PP anlagen formation and mechanisms controlling the num-
ber and location of PP development. The pairing of experimental
data sets with the computational approach described in this paper
has the potential to accelerate the discovery process through pro-
viding new insights into the mechanisms driving immune system
development and function.
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